CD34 and neoplasm: The BMDCs recruited by the tumor include CD133+/CD34+/VEGFR-2+ bone-marrow-derived endothelial progenitor cells (EPCs), which undergo differentiation and incorporation into newly formed blood vessels, where they stimulate tumor vascularization as a result of paracrine signaling [95,97,98].